Manolete Partners PLC Manolete named FT Growth Champion

RNS Number : 4714K

Manolete Partners PLC

01 November 2024

 

1 November 2024

​

 

Manolete Partners Plc

 

("Manolete" or the "Company")

Manolete Partners Plc named as a Financial Times Europe Long-Term Growth Champion 2025

​

Manolete (AIM:MANO), the leading UK-listed insolvency litigation financing company, announces that it has been named a Financial Times Europe Long-Term Growth Champion 2025.

With compound growth measured over a minimum 10-year period, the FT Long-Term Growth Champion award recognises Europe's fastest-growing companies with a commitment to sustainable expansion. It ranks Manolete 152^nd across the whole of Europe and 25^th position in the UK. For the full list please see here.

Manolete Chief Executive and Founder, Steven Cooklin, said: "The whole company is very proud to be named as a Financial Times Europe Long-Term Growth Champion for 2025.

 

"The award is recognition of the dedication and drive of our incredible team of in-house Manolete lawyers, and the strong partnerships they have built with outstanding Insolvency Practitioners and solicitor firms, across all regions of the UK. Those partnerships are the foundation of our reliability, consistency and innovation. Manolete is continuously working to deliver best-in-class insolvency litigation financing services and solutions. It means a great deal to stand among Europe's top-performing firms showing our commitment to sustainable growth and dedication to those we partner with."

 

For further information please contact:

 

 

Manolete Partners	via Instinctif Partners
Steven Cooklin (Chief Executive Officer)
Canaccord Genuity (NOMAD and Broker)	[phone]
Emma Gabriel
Instinctif Partners	[e-mail]
Hannah Scott Tim Linacre	[phone] [phone]

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRAMBBATMTAJBBI